Back
State Street SPDR S&P Pharmaceuticals ETF Vs. Apogee Therapeutics, Inc. Industry Stock Comparison
Buy
65
XPH
State Street SPDR S&P Pharmaceuticals ETF
Last Price:
$54.59
Seasonality Move:
3.02%
Sell
44
APGE
Apogee Therapeutics, Inc.
Last Price:
$84.40
Seasonality Move:
-11.77%
Buy
65
State Street SPDR S&P Pharmaceuticals ETF (XPH)
is a Buy
Is State Street SPDR S&P Pharmaceuticals ETF a Buy, Sell or Hold?
-
The current State Street SPDR S&P Pharmaceuticals ETF [XPH] share price is $54.72. The Score for XPH is 65, which is 30% above its historic median score of 50, and infers lower risk than normal.
-
XPH is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
44
Apogee Therapeutics, Inc. (APGE)
is a Sell
Is Apogee Therapeutics, Inc. a Buy, Sell or Hold?
-
The current Apogee Therapeutics, Inc. [APGE] share price is $84.34. The Score for APGE is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
-
APGE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
XPH Stock Price Chart
What is State Street SPDR S&P Pharmaceuticals ETF's stock price today?
-
The State Street SPDR S&P Pharmaceuticals ETF share price today is $54.72The current trend is relatively stagnant and XPH is experiencing slight buying pressure.
APGE Stock Price Chart
What is Apogee Therapeutics, Inc.'s stock price today?
-
The Apogee Therapeutics, Inc. share price today is $84.34Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and APGE is experiencing buying pressure, which is a positive indicator for future bullish movement.
XPH Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.6 | Sell |
| Relative Strength Index (14 RSI): | 52 | Buy |
| Chaikin Money Flow: | 19896 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (52.73 - 55.85) | Buy |
| Bollinger Bands (100): | (53.01 - 57.27) | Sell |
APGE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 3.18 | Buy |
| Relative Strength Index (14 RSI): | 64.96 | Buy |
| Chaikin Money Flow: | 432550 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (69.1 - 79.44) | Buy |
| Bollinger Bands (100): | (66.23 - 78.47) | Buy |
XPH Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 53.3 | Buy |
| 20-day SMA: | 53.74 | Buy |
| 50-day SMA: | 55.63 | Sell |
| 200-day SMA: | 50.28 | Buy |
| 8-day EMA: | 53.68 | Buy |
| 20-day EMA: | 54.01 | Buy |
| 50-day EMA: | 54.79 | Sell |
| 200-day EMA: | 51.39 | Buy |
APGE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 79.91 | Buy |
| 20-day SMA: | 75.21 | Buy |
| 50-day SMA: | 71.36 | Buy |
| 200-day SMA: | 57.28 | Buy |
| 8-day EMA: | 80.37 | Buy |
| 20-day EMA: | 76.41 | Buy |
| 50-day EMA: | 73.33 | Buy |
| 200-day EMA: | 61.58 | Buy |
State Street SPDR S&P Pharmaceuticals ETF Earnings Growth & XPH Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Apogee Therapeutics, Inc. Earnings Growth & APGE Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.08 per share, a decrease next quarter of $0.21 per share, a decrease this year of $0.63 per share, and a decrease next year of $0.62 per share.
State Street SPDR S&P Pharmaceuticals ETF Technical Analysis
| Mar 20 | Mar 23 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 30 | Mar 31 | Apr 1 | Apr 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 20 | 23 | 24 | 25 | 26 | 27 | 30 | 31 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Apogee Therapeutics, Inc. Technical Analysis
| Mar 20 | Mar 23 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 30 | Mar 31 | Apr 1 | Apr 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 20 | 23 | 24 | 25 | 26 | 27 | 30 | 31 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||